the cardiac arrhythmia pilot study ( caps ) was a randomized , double-blind trial of antiarrhythmic drugs ( encainide , flecainide , moricizine , imipramine and placebo ) in 502 patients with at least 10 ventricular premature complexes/hour , 6 to 60 days after acute myocardial infarction .
C0003811
cardiac arrhythmia
C0079856
moricizine